Yuyu Pharma, Inc. (000227.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 74.91B |
| Enterprise Value | 73.74B |
| P/E Ratio | 4.96 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0.4 |
| Price/Book Ratio | 0.43 |
| Enterprise/Revenue | 0.45 |
| Enterprise/EBITDA | 6.82 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 140.88B |
| Revenue/Share | 9,167.86 |
| Gross Profit | 53.94B |
| EBITDA | 16.63B |
| Net Income | 8.15B |
| Diluted EPS | 463 |
Balance Sheet
| Total Cash | 27.86B |
| Total Cash/Share | 1,769.49 |
| Total Debt | 28.06B |
| Total Debt/Equity | 0.21 |
| Current Ratio | 1.89 |
| Book Value Per Share | 9,282.84 |
Price History
| 52-Week Change | -31.54 |
| 52-Week High | 12,400 |
| 52-Week Low | 5,810 |
| Moving Average 50 Days | 8,446.8 |
| Moving Average 200 Days | 10,182.5 |
Statistics
| Average Volume | 3,546 |
| Shares Outstanding | 5.86M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 115 |
| Trailing Annual Dividend Yield | 3.1 |
| Payout Ratio | 0.17 |
| Last Split Factor | 2:1 |
| Last Split Date | March 30, 2021 |
AD
